“Efficacy and Safety of Ruxolitinib Cream by Anatomic Region in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From TRuE-AD3”, J of Skin, vol. 8, no. 6, p. s453, Nov. 2024, doi: 10.25251/skin.8.supp.453.